XML 54 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Intangible Assets and Royalty Agreement - Summary of Intangible Assets (Details) - USD ($)
9 Months Ended
Jan. 29, 2007
Sep. 30, 2016
Jan. 13, 2016
Dec. 31, 2015
Jan. 05, 2011
Finite-Lived Intangible Assets [Line Items]          
Total   $ 34,002,000   $ 15,627,000  
Less Accumulated amortization and impairment charges   (6,753,000)   (4,864,000)  
Net   27,249,000   10,763,000  
Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Fair value of earn-out   $ 25,620,000 $ 25,620,000    
Licenses          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   7 years      
Gross carrying value   $ 1,699,000   1,009,000  
Licenses | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value     690,000    
Licenses | Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.          
Finite-Lived Intangible Assets [Line Items]          
Acquisition price $ 996,000        
Maximum time of approval 30 days        
Fair value of earn-out $ 200,000        
Contingent royalty to be paid to licensor 3.00%        
Annual royalty payment, minimum $ 50,000        
Licenses | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         $ 13,000
Patents and know-how          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   19 years      
Gross carrying value   $ 17,211,000   8,001,000  
Patents and know-how | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value     9,170,000    
Patents and know-how | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         7,690,000
Finite lived intangible assets   $ 40,000      
Customer & supplier relationships          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   13 years      
Gross carrying value   $ 9,851,000   3,761,000  
Customer & supplier relationships | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value     6,090,000    
Customer & supplier relationships | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value         3,761,000
Non compete agreements          
Finite-Lived Intangible Assets [Line Items]          
Weighted average amortization lives   4 years      
Gross carrying value   $ 1,080,000   0  
Non compete agreements | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value     1,080,000    
Tradenames & trademarks          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   1,838,000   1,008,000  
Tradenames & trademarks | Stability Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived     $ 830,000    
Tradenames & trademarks | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived         1,008,000
In process research & development          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   25,000   25,000  
In process research & development | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived         $ 25,000
Patents in process          
Finite-Lived Intangible Assets [Line Items]          
Gross carrying value, indefinite lived   $ 2,298,000   $ 1,823,000